Powers JH - Search Results

1

Trends in antimicrobial drug development: implications for the future.

Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Spellberg B, et al. Among authors: powers jh. Clin Infect Dis. 2004 May 1;38(9):1279-86. doi: 10.1086/420937. Epub 2004 Apr 14. Clin Infect Dis. 2004. PMID: 15127341

2

Antimicrobial drug development--the past, the present, and the future.

Powers JH. Powers JH. Clin Microbiol Infect. 2004 Nov;10 Suppl 4:23-31. doi: 10.1111/j.1465-0691.2004.1007.x. Clin Microbiol Infect. 2004. PMID: 15522037 Free article. Review.

3

Development of drugs for antimicrobial-resistant pathogens.

Powers JH. Powers JH. Curr Opin Infect Dis. 2003 Dec;16(6):547-51. doi: 10.1097/00001432-200312000-00006. Curr Opin Infect Dis. 2003. PMID: 14624104 Review.

4

Antimicrobial drug resistance, regulation, and research.

Metlay JP, Powers JH, Dudley MN, Christiansen K, Finch RG. Metlay JP, et al. Among authors: powers jh. Emerg Infect Dis. 2006 Feb;12(2):183-90. doi: 10.3201/eid1202.050078. Emerg Infect Dis. 2006. PMID: 16494740 Free PMC article.

5

World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals.

Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. Collignon P, et al. Among authors: powers jh. Clin Infect Dis. 2009 Jul 1;49(1):132-41. doi: 10.1086/599374. Clin Infect Dis. 2009. PMID: 19489713 Review.

6

Risk perception and inappropriate antimicrobial use: yes, it can hurt.

Powers JH. Powers JH. Clin Infect Dis. 2009 May 15;48(10):1350-3. doi: 10.1086/598184. Clin Infect Dis. 2009. PMID: 19361305 No abstract available.

7

Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story.

Nelson JM, Chiller TM, Powers JH, Angulo FJ. Nelson JM, et al. Among authors: powers jh. Clin Infect Dis. 2007 Apr 1;44(7):977-80. doi: 10.1086/512369. Epub 2007 Feb 14. Clin Infect Dis. 2007. PMID: 17342653 Review.

8

Anti-infective research and development--problems, challenges, and solutions.

Bradley JS, Guidos R, Baragona S, Bartlett JG, Rubinstein E, Zhanel GG, Tino MD, Pompliano DL, Tally F, Tipirneni P, Tillotson GS, Powers JH, Tillotson GS. Bradley JS, et al. Among authors: powers jh. Lancet Infect Dis. 2007 Jan;7(1):68-78. doi: 10.1016/S1473-3099(06)70689-2. Lancet Infect Dis. 2007. PMID: 17182346 Review. No abstract available.

9

Do patient data really support the clinical and laboratory standards institute recommendation for lowering third-generation cephalosporin interpretive breakpoints?

Tamma PD, Powers JH. Tamma PD, et al. Among authors: powers jh. Clin Infect Dis. 2013 Aug;57(4):624-5. doi: 10.1093/cid/cit308. Epub 2013 May 8. Clin Infect Dis. 2013. PMID: 23658433 No abstract available.

10

Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance.

Colgan R, Powers JH. Colgan R, et al. Among authors: powers jh. Am Fam Physician. 2001 Sep 15;64(6):999-1004. Am Fam Physician. 2001. PMID: 11578036 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters